Top 50 Medical Startup Investors in Finland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Business Finland
VC Fund
|
8 | Finland, United States, United Kingdom | Grant, Seed, Debt Financing | Software, Biotechnology, SaaS | $53k–$11M |
|
Finnvera Venture Capital
VC Fund
|
7 | Finland, United States, Chile | Seed, Series A | Software, Health Care, Information Technology | $250k–$22M |
|
Voima Ventures
VC Fund
|
6 | Finland, Sweden, Norway | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Artificial Intelligence | $439k–$18M |
|
Lifeline Ventures
VC Fund
|
5 | Finland, United States, United Kingdom | Seed, Series A | Software, Health Care, E-Commerce | $547k–$20M |
|
Maki.vc
VC Fund
|
4 | Finland, Norway, Denmark | Seed, Series A, Pre-Seed | Software, E-Commerce, Information Technology | $900k–$37M |
|
Innovestor
VC Fund
|
3 | Finland, Denmark, Sweden | Seed, Pre-Seed | Software, Health Care, Information Technology | $163k–$4.5M |
|
Butterfly Ventures
VC Fund
|
3 | Finland, Sweden, Norway | Seed, Pre-Seed | Health Care, Software, Information Technology | $110k–$4.4M |
|
Icebreaker.vc
VC Fund
|
3 | Finland, Estonia, Sweden | Pre-Seed, Seed, Series A | Software, Information Technology, Artificial Intelligence | $106k–$25M |
|
Reaktor Ventures
VC Fund
|
3 | Finland, Germany, United States | Seed, Pre-Seed, Series A | Internet, Software, E-Commerce | $137k–$6.6M |
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | |
|
Vesalius Biocapital Partners
VC Fund
|
2 | Belgium, Germany, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Anssi Vanjoki
Angel
|
2 | Finland | Angel, Series A | Medical, Hardware, Health Care | |
|
Asko Schrey
Angel
|
2 | Finland | Seed, Angel | Software, Artificial Intelligence, FinTech | |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Metsola Ventures
VC Fund
|
2 | Finland | Series A | Medical, mHealth, Health Care | $2.2M–$4.8M |
|
Samsung Venture Investment
VC Fund
|
2 | South Korea, United States, India | Series A, Series B, Seed | Information Technology, Software, Artificial Intelligence | $45k–$60M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
Inventure
VC Fund
|
2 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$23M |
|
Cascara Ventures
VC Fund
|
2 | Germany, Finland, The Netherlands | Series A, Seed, Series B | Medical, Health Care, Biotechnology | |
|
Springvest
VC Fund
|
2 | Finland | Series A, Seed | Biotechnology, Health Care, Energy | $1.5M–$53M |
|
Jyri Engestrom
Angel
|
2 | United States, Finland, Spain | Seed, Pre-Seed, Series A | Software, Apps, Internet | $600k–$20M |
|
Nuard Ventures
VC Fund
|
1 | Finland, Germany, United States | Seed | IaaS, Video, Fashion | $339k–$680k |
|
Ascend Capital Partners
VC Fund
|
1 | Finland, Israel, Austria | Series A, Seed | Health Care, Medical Device, Software | $1.5M–$12M |
|
Athensmed
VC Fund
|
1 | Finland | Seed, Series A | Health Care, Medical, mHealth | $1.1M–$1.3M |
|
Hadean Ventures
VC Fund
|
1 | Norway, Sweden, Germany | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Capricorn Partners
VC Fund
|
1 | Belgium, United States, The Netherlands | Series A, Series B | Biotechnology, Software, Health Care | $3.3M–$42M |
|
Torrey Pines Investment
VC Fund
|
1 | United States, Russian Federation, The Netherlands | Seed, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $3M–$3.1M |
|
J12
VC Fund
|
1 | Sweden, Germany, Norway | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $420k–$65M |
|
Jukka Tapaninen
Angel
|
1 | Finland | Seed | Medical, Software, Education | |
|
Ali Omar
Angel
|
1 | Finland, United States, Estonia | Seed, Pre-Seed, Angel | Software, SaaS, Artificial Intelligence | $53k–$2.1M |
|
Korpun Siemen
VC Fund
|
1 | Finland | Seed, Angel | Software, Marketing, Information Technology | $480k–$1.3M |
|
SHS Capital
VC Fund
|
1 | Germany, Switzerland, France | Series B, Series C | Health Care, Medical Device, Medical | $4.9M–$60M |
|
DigiTx Partners
VC Fund
|
1 | United States, Canada, Finland | Series A, Seed, Series B | Health Care, Medical, Artificial Intelligence | $2.7M–$43M |
|
XR Invest
VC Fund
|
1 | Finland, United States | Series A, Series C | Medical Device, Sensor, Medical | |
|
Metaplanet
VC Fund
|
1 | United States, United Kingdom, Estonia | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $2.4M–$62M |
|
Tesi
VC Fund
|
1 | Finland, United States, Switzerland | Series A, Series B | Software, Manufacturing, Health Care | $2.2M–$41M |
|
Gaingels
VC Fund
|
1 | United States, Canada, Mexico | Seed, Series A, Series B | Software, Health Care, Artificial Intelligence | $1.4M–$100M |
|
Marten Mickos
Angel
|
1 | Finland, United States, Sweden | Seed, Series A, Convertible Note | Software, Enterprise Software, Internet | $550k–$4.5M |
|
Petri Pöyhönen
Angel
|
1 | Finland | Series A | Medical, Biotechnology, Medical Device | |
|
Esther Dyson
Angel
|
1 | United States, Canada, Russian Federation | Seed, Series A | Health Care, Software, Medical | $270k–$16M |
|
Way to Wellville
VC Fund
|
1 | United States, Finland | Series B, Series A | Software, Medical, Health Care | $12M–$15M |
|
Lynx Capital
VC Fund
|
1 | Finland | Series A, Seed | Health Care, Medical, Therapeutics | |
|
Ananda Impact Ventures
VC Fund
|
1 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | $1.6M–$17M |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $5.1M–$120M |
|
Visionplus
VC Fund
|
1 | Finland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Internet | $77k–$14M |
|
M Ventures
VC Fund
|
1 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Cor Group
VC Fund
|
1 | Finland | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $2.4M–$8.7M |
|
Kustaa Piha
Angel
|
1 | Finland | Seed | Health Care, Health Diagnostics, Medical Device | $549k–$1.3M |
|
Unifund
VC Fund
|
1 | Finland | Software, Collaboration, Management Consulting | ||
|
Debiopharm Innovation Fund
VC Fund
|
1 | Switzerland, United States, France | Series A, Seed, Pre-Seed | Health Care, Biotechnology, Software | $943k–$25M |
| Access all 95 investors in Finland Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.
Show more...Investment focus
- Industry: Software, Biotechnology, SaaS
- Stage:Grant, Seed, Debt Financing
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 197
- Round size: Seed $297k–$3.5M; Grant $53k–$11M; Debt Financing $241k–$5.8M
- Lead/follow: 42% lead, 58% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Agileday — Connect your business elements in one tool and manage your entire operations with Agileday. Match sales, projects, and talent together and optimize your business.
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Valio — We are Valio Group: the most innovative dairy and food company in the world.
Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Finland, United States, Chile
Investor stats
- Total investments: 94
- Round size: Seed $250k–$2.3M; Series A $1.7M–$22M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
- CHAOS — CHAOS is an urban forecasting company for real estate investors and city developers. Our AI platform processes urban data and crowd insights to forecast investment and development for creating liveable cities.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 59
- Round size: Seed $1M–$5.9M; Pre-Seed $439k–$2.1M; Series A $3.8M–$18M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Kuva Space — Kuva Space improves life on Earth through daily, space-borne hyperspectral imaging and AI. We offer Earth observation solutions for more sustainable business.
- Sofi Filtration — Innovation in Industrial Liquid Filtration
Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 179
- Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $171M in 2023
Portfolio highlights
- Realm — Realm is a search engine for the workplace reimagined with AI. Designed to help fast-moving teams better leverage their collective knowledge.
- Thor Dynamics — Headquartered in Orlando, Florida, with a European base in Finland, Thor Dynamics specializes in directed energy systems for defense against drones and drone swarms. The company’s innovative solutions are available worldwide to protect critical infrastructure and enhance national security. Laser Armor™ is a complete directed energy counter-dronesolution. Utilizing advanced radar and optical systems it can detect, track, and target hostile targets. High-power directed energy from Thor’s Laser Engines then eliminates the threat in seconds. Multiple safety systems ensure accurate target identification and minimal collateral damage.
- Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
We partner with deep tech and brand-driven companies obsessed in challenging category norms. The Nordics are our home, but we take on a global front in spotting the unexpected - from B2B to B2C, with a sweet spot for scientific advances, strong IP, and customer understanding that looks beyond convention.We invest in early stage companies: fromtheir inception to series A and beyond. We share in the vision of founders as champions and challengers, drawing on our experiences from scaling some of the strongest tech companies ourselves.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Finland, Norway, Denmark
Investor stats
- Total investments: 93
- Round size: Seed $900k–$8M; Pre-Seed $1.1M–$2.7M; Series A $3.3M–$37M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Yaak Technologies ApS — Safety in urban self-driving is currently an afterthought. At Yaak, we distill safety from driving experts for the next generation of human and autonomous driving.
- IXI — Discover adaptive glasses with autofocus lenses that adjust to your viewing needs, providing seamless clarity at any distance.
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Denmark, Sweden
Investor stats
- Total investments: 79
- Round size: Seed $507k–$4.5M; Pre-Seed $163k–$2M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- Innomost — Innomost develops and produces high-value bioactive ingredients from forest industry side streams that enable customers to make innovations in the cosmetic beauty industry. Its current product portfolio consists of birch charcoal powder, birch bark powder, betulin, suberin, and azelaic acid, which can trigger innovation in all cosmetic productcategories including skincare, haircare, body care, decorative cosmetics, and oral care.
- Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
- Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Finland, Sweden, Norway
Investor stats
- Total investments: 87
- Round size: Seed $219k–$2.1M; Pre-Seed $110k–$4.4M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Atium — Clean water is one of the largest future challenges we stand before, and toxic pollutants are a large contributing factor. Heavy metals are some of the most toxic chemicals to human health and it is our goal, through our innovation, to contribute to a world where water treatment is more environmentally friendly and effective. Atium exists to helpensure clean water, for everyone.
- Reactional Music — Reactional Music is creating a new commercial layer for the global games industry that uses premium, licensed music to drive both user acquisition and player engagement. The company’s technology allows developers and publishers to integrate commercial music at two critical points in the player lifecycle:- Music in User Acquisition – improvingconversion, ROI, and campaign lifespan in playable ads and performance marketing.- Music in Games – increasing retention, session length, and monetization through adaptive, personalized music experiences.Reactional’s platform combines a patented rule-based adaptive music engine, a licensed catalog of more than six million tracks, and an automated rights and royalty system. The technology is already integrated with Unity and Unreal and is deployed across live projects with leading publishers and studios.
- Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Pre-Seed, Seed, Series A
- Geography: Finland, Estonia, Sweden
Investor stats
- Total investments: 122
- Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $22M in 2021
Portfolio highlights
- Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
Reaktor Ventures has moved to the next phase by focusing its efforts to actively supporting current portfolio companies. This means that the fund has ended its investment period and is not investing into new companies. Between 2013 and 2018 we have invested into 42 different companies and one early stage fund. We will naturally keep makingfollow-up investments to current portfolio companies.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 54
- Round size: Seed $137k–$2M; Pre-Seed $159k–$1.8M; Series A $1.7M–$6.6M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Valpas — Valpas is the hygiene protocol that reassures your future guests and keeps your hotel clean from the most uncontrollable: bed bugs
- Swappie — Buy refurbished iPhones at an affordable price - Swappie offers refurbished and cheap iPhones with a free 12-month Swappie warranty.
- Videoly — The easiest way for online retailers to get hand-picked and automatically embedded product videos.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 271
- Lead/follow: no public data
Portfolio highlights
- Supira Medical — Next Generation Solution for Temporary Mechanical Circulatory Support Developing a low-profile, high-flow percutaneous ventricular assist device (pVAD) for high risk coronary intervention and cardiogenic shock. Clinical Need Percutaneous ventricular assist devices (pVADs) are placed to provide temporary mechanical support, assisting the native pumping action of
- Callio Therapeutics — Callio Therapeutics focuses on developing next-generation, multi-payload antibody-drug conjugates to maximize therapeutic benefits.
- Newleos Therapeutics — Newleos Therapeutics is a biotech startup dedicated to producing safer and more effective neuroscience medicines.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: Belgium, Germany, The Netherlands
Investor stats
- Total investments: 55
- Lead/follow: no public data
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
As Executive Vice President and General Manager of Multimedia, Nokia, Anssi Vanjoki heads a business group that is responsible for developing Nokia Nseries multimedia computers and associated experiences and services. This fast growing segment of consumer electronics will shape our lives in a fundamental way. A highly respected brand authoritywith over 25 years of marketing experience, Anssi has been a driving force in Nokia's efforts to address the mobile markets. His work has focused on developing Nokia's brand durability, loyalty and continuity, while, at the same time, advancing Nokia's vision of a mobile world. Anssi joined Nokia in 1991 and was named Vice President, Sales, Nokia Mobile Phones, before his promotion in 1994 to Senior Vice President, Nokia Mobile Phones Europe and Africa. In 1998 he was made Executive Vice President, Nokia Mobile Phones Europe and Africa and became a member of the Group Executive Board of Nokia. In addition, in 1999, Anssi took responsibility for Nokia's Digital Convergence Unit and, in 2002, also headed up the Business Unit Management. He was appointed to his present position on January 1st 2004. Prior to joining Nokia, Anssi held a variety of management positions at 3M Corporation. Anssi is the Chairman of the Board of Amer Group, and was a member of the Governing Committee of the European Foundation for Quality Management 2001 - 2003. He is a Knight, 1st Class, of the Order of the White Rose of Finland. Anssi holds a master's degree in economics from the Helsinki School of Economics and Business Administration.
Show more...Investment focus
- Industry: Medical, Hardware, Health Care
- Stage:Angel, Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Asko Schrey
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 5
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Zefort — Zefort is a powerful contract management software. Sign, store, share contracts and easily with your team. Set reminders and use a powerful search.
- ContractZen Governance Suite — ContractZen corporate governance software is ideal for contract management, board meeting management, entity management, e-signature & virtual data room (VDR).
- ReceiptHero — Say goodbye to paper receipts. Cut operational costs, reduce waste and deliver a better in-store experience for customers.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 29
- Round size: Series A $1.3M–$73M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Metsola Ventures
Show more...Investment focus
- Industry: Medical, mHealth, Health Care
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 2
- Round size: Series A $2.2M–$4.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Samsung Venture Investment is plays the role of driving the discovery and development of new businesses and technologies.
Show more...Investment focus
- Industry: Information Technology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: South Korea, United States, India
Investor stats
- Total investments: 128
- Round size: Seed $45k–$60M; Series A $1.6M–$25M; Series B $3M–$23M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- N.THING — Established in January 2014, N.THING is a Seoul-based Agri-Food tech company leading innovation in agricultural products, by extension, in the farm-to-table food value chain by combining IoT technology and data. It developed the world’s first modular vertical farm ‘CUBE’ which is easy to expand. N.THING CUBE is a modularized farm with massproductivity where a dedicated OS provides the most optimized environment for each crop so as to create maximized efficiency. N.THING is the world’s first smart farming company that won the iF Design Award, Architecture in 2020. Also, it is a winner of Best of Innovation at the CES 2020 for its excellence in technology, which is the first ever in the agricultural field. N.THING is planning to expand its business on a large scale this year after it successfully completes the PoC process in the U.A.E. Our North American branch office located in New York. N.THING hopes to connect people to nature, things to things, people to things, and people to people through IoT technologies by creating Number of Things out of Nothing. .CUBE : CUBE is internet connected modular container vertical farm. It's an ultimate indoor farm which contains LED technology, real time monitoring system through IoT sensors, collected cultivation data, and upgradable software. We deliver the farm of the desired container form to the desired place.SQUARE : SQUARE is modular hydroponic kit. SQUARE can connect each module and share water. Users can connect as many as they want, grow greens and herbs, and make food great themselves. Each Square consists of four Pickcells, which contains special nutrient-rich sponge. With special sponge and hydroponic, it gives the most simple and effective gardening experience.Planty : Planty is the first Internet-connected social pot in the world. Planty gives pleasure to grow plants with your family, friend, and colleague. Planty enables the user to monitor the environmental information on temperature, soil moisture, and ambient light around plants and give water to plants any me or anywhere.Life : Life is a smart gardening journal aimed at the gardening sector. Plant lovers and gardeners are able to record their gardening activities and information and share them through Social Media. The user can easily insert weather data, location data, gardening activities, and plants’ events. Moreover, all the gardening data can be shared through social media.Sikmulsung: Sikmulsung is our show room to explore 'freshness' of our product and service. It is a place for everyone seeking for 'freshness' in visual, in texture, in taste, in flavor or even in atmosphere with, N.THING's in-store farm, exclusively made for Sikmulsung, special F&B's and our end products.
- MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
- Aim Intelligence — Leading AI Security & Safety Solutions Provider - Specializing in AI Risk Detection, Mitigation, and Elimination through Advanced Red Teaming and Defensive Systems | Leading provider of AI Security, Safety, and Compliance solutions
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 16
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.8M
- Lead/follow: 94% lead, 6% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 165
- Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Finch — Optimize building design with AI and graph technology. Get immediate feedback on performance, detect errors and find optimal solutions.
- Reveel — Say goodbye to paper maps, brochures, and outdated audio guides. Reveel offers digital solutions for destinations such as UNESCO sites, sights, museums, cities, hotels and parks, taking the visitor experience to the next level. Become part of the smart destination movement, enhance the visitor experience, and discover the future of travel.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
96 Normal 0 false false false EN-GB X-NONE X-NONE
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed, Series B
- Geography: Germany, Finland, The Netherlands
Investor stats
- Total investments: 12
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Fiagon —
- Surgify — Surgify are currently preparing the commercialization of a novel technology for bone surgery at Aalto University with financial support from Tekes (Finnish Funding Agency for Innovation). To enable continuous communication with clinicians, they have been working in close cooperation with Neurosurgical Department of Helsinki University CentralHospital, part of HUS (The Hospital District of Helsinki and Uusimaa).
- SurgicEye — SurgicEye designs intra-operative imaging and instrument navigation solutions for surgical procedures. It offers a navigated radio-guided surgery based on the handheld 3-D freehand SPECT imaging technology called the declipse SPECT open surgery, an intraoperative 3D imaging system for invasive sentinel lymph node biopsy called the declipse SPECTLaparascopy, and a mobile SPECT imaging solution with a high resolution on a small footprint called the declipse SPECT imaging probe. The company also advises clients on medical device development, requirement engineering and software specification for medical devices, software development for medical devices, testing of software for medical devices, and support in the design and conduction of clinical studies.Dr. Jörg Traub founded SurgicEye in 2008, with its headquarters in Munich in Germany.
The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 23
- Round size: Seed $1.5M–$7.6M; Series A $3.6M–$53M
- Lead/follow: 74% lead, 26% follow
Portfolio highlights
- ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
- MedicubeX — MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.
- CurifyLabs — CurifyLabs enables 3D printed personalized medicines in pharmacies and hospitals. Always close to the patient.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Jyri Engeström is an Investor and Partner of Yes VC. He attended Lancaster University
Show more...Investment focus
- Industry: Software, Apps, Internet
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Finland, Spain
Investor stats
- Total investments: 30
- Round size: Seed $600k–$4.7M; Series A $2.8M–$20M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Jow — Jow is a grocery shopping app that simplifies shopping and gives advice of what to eat. This app offers free and simple recipes that adapt to the customer's taste. It automatically creates a customized menu with delicious recipes and fills the cart with all the ingredients necessary for cooking.Jow was founded in 2017 and is headquartered inParis, France.
- Orchid Labs — Orchid Labs is an open-source project committed to ending surveillance and censorship on the internet. Orchid uses an overlay network built upon the existing internet, which is driven by a peer-to-peer tokenized bandwidth exchange, creating a more inclusive, liberated internet. Orchid Labs was founded in 2017 by Dr. Steven Waterhouse, Jay Freeman,Brian J. Fox, Gustav Simonsson, and Stephen Bell.
- Gyroscope Innovations — Gyroscope Innovations is a new OS for the human body. It was started by Anand Sharma in 2014 as a personal project called April Zero.
Nuard Ventures invests in innovative early stage companies.
Show more...Investment focus
- Industry: IaaS, Video, Fashion
- Stage:Seed
- Geography: Finland, Germany, United States
Investor stats
- Total investments: 6
- Round size: Seed $339k–$680k
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- WARD — WARD is a fantasy sport game, where fans can watch their favourite eSports matches and predict what will happen in real time.WARD is a startup out of Berlin which has created a “pick and predict” real-time prediction smartphone game, where players can win real prizes. People love to watch e-sports. We believe on these occasions they still want tobe able to participate.However, until now no product has offered anything other than the ability to watch. There’s been no way for fans to spectate, participate, analyse and predict the outcomes of their favourite games.
- MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
- Polka Dot Studio — Kalian Bisa Memasang Taruhan Online Dengan Sangat Mudah Dan Nyaman Di Situs DEWAHOKI Yang Sudah Resmi Di Indonesia
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Series A, Seed
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 18
- Round size: Seed $1.5M–$9.3M; Series A $2.2M–$12M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Pionix — open source software as a service for charging stations / e-mobility
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
- Nanoflex Robotics — Nanoflex Robotics develops a soft robotic system that precisely inserts specially made guidewires and catheters deep into the brain. The company provides patented magnetic navigation technology but also the necessary surgical devices. Nanoflex Robotics was established in May, 2021 in Zurich, Switzerland.
Athensmed Oy
Show more...Investment focus
- Industry: Health Care, Medical, mHealth
- Stage:Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 4
- Round size: Seed $1.1M–$1.3M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
- Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Germany
Investor stats
- Total investments: 30
- Round size: Series A $4.3M–$79M; Series B $4.5M–$68M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Belgium, United States, The Netherlands
Investor stats
- Total investments: 117
- Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Azumuta — Unite Connected Worker and MES capabilities to build the execution platform that coordinates, governs, and continuously improves operational work on the shop floor, across humans, AI agents, and robotic systems
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- VOID Technologies — VOID Technologies is a groundbreaking materials science company spun out of Kimberly-Clark to commercialise the VO+ technology. Our business model is based on supplying VO+ additive masterbatches to film manufacturers.
Torrey Pines Investment, founded in 2002, is a specialty life-science investment company located in San Diego.Torrey Pines has a team of investment professionals with extensive experience in entrepreneurship, venture capital and operations. Our firm has created biopharma incubators investing in early development stage assets from internationalpharma and biotech partners in CNS, oncology, and virology areas to bring them to commercial success through pharma partnering and M&A.We are committed to capitalizing on the unique opportunities in biotech and pharma, where we can add value in development or regulatory strategy by utilizing resources of our portfolio CRO companies. We seek to leverage our industry knowledge, network of industry and financial contacts, and internal resources to assist our portfolio management in developing and executing their business strategy. Our bottom line is to help our companies achieve growth, build value and realize wealth.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: United States, Russian Federation, The Netherlands
Investor stats
- Total investments: 32
- Round size: Seed $3M–$3.1M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $60M in 2017
Portfolio highlights
- Mondego Bio — Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
- BIMINI Biotech — BIMINI Biotech is a startup that develops innovative therapeutic strategies for oncology. It is developing therapeutic strategies that target the growth hormone receptor (GHR) and its interaction with insulin-like growth factor 1 (IGF-1) for oncology, metabolic diseases, and aging.The company was founded in 2019 and is based in Leiden, TheNetherlands.
- Avelas Biosciences — At Avelas Biosciences, their mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients.
J12 is a thesis-driven venture capital firm partnering early with technical founders across Europe to build category-defining data and AI companies across infrastructure, tooling, and domain-specific applications
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Germany, Norway
Investor stats
- Total investments: 57
- Round size: Seed $1.5M–$7.7M; Pre-Seed $420k–$1.7M; Series A $7M–$65M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Treyd — Working capital for fast growing brands. Order Now, Pay Suppliers Later
- VALIDIO — Real-time data validation and data quality monitoring for modern data teams. Abstracting complexity away from data engineering.
- CURE: One app, all things health — CURE connects local pharmacies with customers throughout its platform and delivers healthcare-related goods directly to the consumer.
Jukka Tapaninen is an experienced IT business executive and a board member at Fimmic. Jukka also holds board positions at weVision, Addoro Ab, Findity and MeshWorks Wireless Oy.Jukka has a strong background in the IT industry on managing companies and business units globally. His leadership experience, from large companies like SAP and HP, aswell as from strong midsize companies has given him industry knowledge and excellent network within the strategic ecosystem and major customers. Jukka has experience in working in the United States, Singapore and multiple locations in Europe that have given him a good understanding on how business is done in different parts of the world.Jukka holds a M.Sc. degree from the Helsinki School of Economics.
Show more...Investment focus
- Industry: Medical, Software, Education
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Aiforia — Aiforia provides software and services for pathologists, scientists and healthcare professionals to use artificial intelligence for image analysis.
Ali Omar is a Member of the Finnish Business Angels Network. He attended Aalto University and the University of Oulu.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Finland, United States, Estonia
Investor stats
- Total investments: 62
- Round size: Seed $263k–$2.1M; Angel $53k–$1.6M; Pre-Seed $163k–$724k
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- MÖ Foods — MÖ Kaurajogu is domestic, completely herbal and above all delicious. All our products are manufactured in Central Ostrobothnia, Lohtaja.
- React & Share — High volume, high quality feedback directly from your customers. React & Share helps digital comms teams improve their websites and satisfy their customers.
- Plain Complex — VUOROX IS AN AI-POWERED ROSTER SCHEDULING APP FOR HEALTHCARE
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Korpun Siemen is backed by 33 investors who have combined their initial investment activities and have extensive experience in start-up, growth and family businesses in various industries. The company includes active angel investors, entrepreneurs in growth companies and investors who have already exited their companies.
Show more...Investment focus
- Industry: Software, Marketing, Information Technology
- Stage:Seed, Angel
- Geography: Finland
Investor stats
- Total investments: 10
- Round size: Seed $480k–$1.3M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Mobal — It is time to get your Business Profiles in shape. Meet your customers where they are and stand out where it matters most.
- Remod — Remod provides holistic IT surveys, backup services, cyber control, functional programming, data processing, incident response, secure systems, network design, and proof of concept development.
- Builderhead — Builderhead is an easy-to-use construction management software that helps owners, developers and general contractors complete construction projects on time and within budget.
SHS is an independent private equity company. Their focus is on investments in the MedTech, Life Sciences, Diagnostics, and Digital Health sectors.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Series C
- Geography: Germany, Switzerland, France
Investor stats
- Total investments: 43
- Round size: Series B $4.9M–$60M; Series C $6.6M–$14M
- Lead/follow: 53% lead, 47% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- MESI Medical — MESI mTABLET replaces disconnected diagnostic tools with one integrated, user-friendly solution.
- ROTOP — ROTOP is a pharmaceutical company. They manufacture cGMP-compliant radiopharmaceuticals for diagnostics and therapy in the fields of nuclear medicine. They provide API/precursor synthesis, analysis kit development, project management, full regulatory support spect, PET, quality control, and therapy services. Their customers contact throughemail and phone number.
- Salvia BioElectronics — Our mission is to give people with migraine a better life. As a pioneer in the field of medical devices, Salvia BioElectronics is passionately committed to empowering people with migraine to reclaim their lives.
At DigiTx Partners,we believe that the pace of change in healthcare will only accelerate in the coming years. We believe that there are many smart people with great insights and drive who are developing innovative technologies and solutions. We look forward to supporting innovative companies that will make a difference in our healthcareecosystem, from companies that will change how patients navigate the healthcare system, that will integrate the disparate elements that comprise both diagnosis and treatment, that will speed the development of more effective drugs and that will enhance and enable efficient and accurate physician-patient interaction. DigiTx Partners looks forward to investing in those digital health companies that strive to keep all of us in better health.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Finland
Investor stats
- Total investments: 30
- Round size: Seed $2.7M–$7.8M; Series A $4M–$25M; Series B $6M–$43M
- Lead/follow: 50% lead, 50% follow
- Last fund: May invest from a new fund soon — raised $75M in 2018
Portfolio highlights
- Cerula Care — Cerula Care specializes in behavioral health services for people with chronic conditions.
- Neon Health — Neon accelerates patient access to critical care by jumping through all the hoops to onboard and adhere to life-saving drugs, treatments.
- Auxira Health — Auxira Health is committed to providing virtual practice extensions that seem like a natural extension of your team, bringing order to the chaos of modern healthcare.
XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.
Show more...Investment focus
- Industry: Medical Device, Sensor, Medical
- Stage:Series A, Series C
- Geography: Finland, United States
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Estonia
Investor stats
- Total investments: 98
- Round size: Seed $2.4M–$12M; Series A $5.9M–$40M; Series B $23M–$62M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Vok Bikes — We build heavy-duty cargo bikes and rent them out to on-demand delivery companies and their couriers — no surprises, no extra fees. Currently active in Tallinn and Vilnius and expanding to London and Berlin Q4 2021.
- Zama — Secure data privacy of your application with the Zama Concrete framework and its fully homomorphic encryption library
- Lightyear — Lightyear is a simple and approachable way to invest your money globally without unnecessary barriers and fees.
Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570
Show more...Investment focus
- Industry: Software, Manufacturing, Health Care
- Stage:Series A, Series B
- Geography: Finland, United States, Switzerland
Investor stats
- Total investments: 142
- Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
- Kide Science — Kide Science supports young children's scientific thinking through play-based learning, which predicts better learning outcomes in school.
- MaaS Global — Whim combines all the transportation you need: Public transport, shared cars, bikes, e-scooters, taxis, and more! One app to plan, book, and pay.
Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 755
- Round size: Seed $1.4M–$8M; Series A $6M–$40M; Series B $16M–$100M
- Lead/follow: 1% lead, 99% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Paxton — Regulatory Intelligence, with the speed of Generative AI.
- Limbic — Limbic creates neuroscience of emotion packaged for developers. With just a few lines of code, anyone can make their app emotionally intelligent. Use the SDK to build products that interact with your user as naturally as interactions between two humans.
- Sharper Sense — Neuromodulation for Clear Senses
Marten Mickos is the CEO of HackerOne, Inc. the leading vulnerability coordination and bug bounty platform. Previously Marten was the CEO of Eucalyptus Systems, acquired by Hewlett-Packard where he served as head of the cloud business. As the CEO of MySQL AB from 2001 to 2008, Marten grew that company from a garage start-up to the second largestopen source company in the world. Marten holds a M.Sc. in technical physics from Helsinki University of Technology in his native Finland.
Show more...Investment focus
- Industry: Software, Enterprise Software, Internet
- Stage:Seed, Series A, Convertible Note
- Geography: Finland, United States, Sweden
Investor stats
- Total investments: 15
- Round size: Seed $550k–$4.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Queer Spaces — Spaces is a group chat platform for building queer communities, and the first app to serve the entirety of the LGBTQ+ spectrum.
- Tangled — The next-generation social coding platform.
- Pandatron — With clients like SAP, Universal Pictures & Skanska, Pandatron is a startup that supports change management. We do it by scaling AI-driven coaching 1-on-1s to every employee, which also allows us to measure change.
Petri Pöyhönen
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Series A
- Geography: Finland
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Esther Dyson - Founder @ Way to Wellville
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A
- Geography: United States, Canada, Russian Federation
Investor stats
- Total investments: 72
- Round size: Seed $270k–$4.3M; Series A $1.5M–$16M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- The Beans — The Beans offers a software application platform that creates personalized cash flow plans designed for its users. The Beans is Simplifying the path to financial balance through design and technology so that people can focus on what they love.
- NextSense — Introducing NextSense Smartbuds: EEG-powered earbuds that go beyond sleep tracking. Backed by science, Smartbuds provide real-time insights to help you achieve deeper, more restorative sleep. Comfortable, intuitive, and easy to use, Smartbuds empower you to wake up your best self.
- Openwater — OPENWATER - THE FUTURE OF NEURAL DIAGNOSTICS IN THE PALM OF YOUR HAND.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Wellville is a 10-year national nonprofit project to achieve equitable wellbeing. We support the efforts of The Wellville 5: Five US communities.
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Series B, Series A
- Geography: United States, Finland
Investor stats
- Total investments: 7
- Round size: Series B $12M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Upbeat — Upbeat is a software-powered next-generation PR agency that focuses on media marketing for various companies. The company is a team of software engineers and PR professionals working together to bring the old-school PR industry to the modern world. Upbeat turns story ideas to into something presentable by connecting the best stories to the beststorytellers. They also manage email outreach and follow-ups and keep track of pitch's progress with real-time analytics and email updates. And, its software is also an avenue to monitor media opportunities on company's behalf.
- Trimian — Startup based in Menlo Park, focusing on mobile apps. The name comes from 'tri-simian', referring to the three wise monkeys.
- Big Health — Our mission is to help millions back to good mental health. Our digital therapeutics are safe and effective non-drug alternatives for mental health.
cross-border, healthcare, life science, investment, VC, China, US
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Series A, Seed
- Geography: Finland
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Marginum — Pioneering the next-generation quantitative surgical techniques.
- Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
- Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 71
- Round size: Seed $1.6M–$17M; Series A $3.8M–$17M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $121M in 2022
Portfolio highlights
- DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
- Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
- AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 213
- Round size: Series A $5.1M–$81M; Series B $11M–$120M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Bionano Genomics — Discover how Bionano is striving to elevate health and wellness for all through optical genome mapping (OGM) solutions that transform the way the world sees the genome.
- LOQUS23 THERAPEUTICS — LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease and other triplet repeat diseases.
WE HELP YOU TO GROW FASTER!
Show more...Investment focus
- Industry: Software, Information Technology, Internet
- Stage:Seed, Series A
- Geography: Finland, United States, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $77k–$1.3M; Series A $2M–$14M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Film Finances — Discover Film Finances Inc., the global leader in film completion guarantees, ensuring on-schedule and on-budget delivery for over seven decades. Explore our services and industry expertise.
- LiveMusicStage — We're a live music venue online. We let you to actually take part in the shows and interact with the bands while they're playing. You're always in the front row
- Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 170
- Round size: Seed $2.4M–$22M; Series A $5.6M–$49M; Series B $15M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
- Biolinq — Introducing a revolutionary platform for metabolic health.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $2.4M–$8.7M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Gosta Labs — Focus on care
- Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
- Nightingale Health — The most advanced health check for the health industry.
Healthcare business development, management, and investing. Very good knowledge on healthcare services and public health. Kustaa Piha is interested in new business and investment opportunities and better ways of producing excellent healthcare services.
Show more...Investment focus
- Industry: Health Care, Health Diagnostics, Medical Device
- Stage:Seed
- Geography: Finland
Investor stats
- Total investments: 5
- Round size: Seed $549k–$1.3M
- Lead/follow: 80% lead, 20% follow
Portfolio highlights
- Sooma — Sooma provides unique therapy solutions that combine effectiveness with ease-of-use. Therapies are based on tDCS method.
- Klinik — Klinik® is an innovative health website designed from the very beginning to meet the needs of users. They offer advanced tools for consumers to identify their conditions and to treat them properly, and if needed, they connect them with matching health professionals. It’s a unique platform for health experts to show their true expertise toconsumers. Main characteristics of their offering are:1) Easy access to qualified and reliable health and medical information2) Helping people to identify their conditions3) Providing people valid evidence-based info on self care4) Integrating professional healthcare providers with users requesting additional medical.
- Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.
Show more...Investment focus
- Industry: Software, Collaboration, Management Consulting
- Geography: Finland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
- PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Pre-Seed
- Geography: Switzerland, United States, France
Investor stats
- Total investments: 37
- Round size: Seed $943k–$6M; Series A $3.5M–$25M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Neuroute —
- Altis Labs — Altis Labs is the computational imaging company advancing precision medicine. We believe that medical imaging is the richest source of untapped information. Life sciences companies use our software platform, Nota, to accelerate all stages of clinical development. Trained on over 140 million longitudinal real-world images with associated clinicalinformation, our deep learning models predict clinically meaningful outcomes to quantify treatment effect more accurately.
- VeriSIM Life — Make confident decisions about drug development, quickly and efficiently, using a decision-engine that takes your toughest translational questions and generate actionable insights to guide your next steps.
Medical Investor funding in Finland at a glance
Stats across 86 deals from 95 investors.
Access all 95 investors in Finland Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 95 investors investing in Finland Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!